MIND Prize
The MIND Prize funds bold, interdisciplinary research by early-to-mid-career investigators to advance understanding and treatment of neurodegenerative diseases like Alzheimer’s and Dementia.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026 (Letter of Intent, projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; includes up to 10% indirect costs)
Summary: Supports early-to-mid-career investigators pursuing bold, interdisciplinary research on neurodegenerative diseases.
Key Information: Forecasted grant—dates and details subject to change; check program page for updates.
Description
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize, administered by Pershing Square Philanthropies, is designed to accelerate breakthroughs in neurodegenerative disease research by empowering early-to-mid-career investigators to pursue high-risk, high-reward projects. The prize funds innovative, interdisciplinary research that advances the understanding, diagnosis, or treatment of neurodegenerative diseases such as Alzheimer’s Disease and Dementia. Projects may span development of new technologies, brain mapping, therapeutic strategies, or other approaches that challenge conventional paradigms. Awardees join a collaborative network of researchers and benefit from industry mentorship, networking events, and annual retreats.
